Brainsway Reports Financial Results for Second Quarter of 2018 and Provides Corporate Update
27 août 2018 08h00 HE
|
Brainsway Ltd.
Second quarter revenues of $3.7 million represent a quarterly record and a 57% increase over second quarter 2017 Recently announced FDA clearance of Deep TMS system for treatment of OCD expected to...
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive-Compulsive Disorder
20 août 2018 08h00 HE
|
Brainsway Ltd.
BrainsWay’s deep transcranial magnetic stimulation (Deep TMS) system is a best-in-class device designed to maximize electromagnetic stimulation of deep and broad brain regions, helping to launch a new...
Sandhya Prashad, M.D., Now Offering BrainsWay Deep TMS to Patients With Depression in Houston Area
10 juil. 2018 09h00 HE
|
Brainsway Ltd.
BELLAIRE, Texas, July 10, 2018 (GLOBE NEWSWIRE) -- Houston psychiatrist Sandhya Prashad, M.D., today announced that her practice is now offering BrainsWay Deep Transcranial Magnetic Stimulation...
Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder
07 juin 2018 08h15 HE
|
Brainsway Ltd.
Unique Biomarkers Sought to Enable Personalized Medicine Approach for Treatment of Post Traumatic Stress Disorder (PTSD) HACKENSACK, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Brainsway Ltd....
Brainsway Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update
29 mai 2018 07h00 HE
|
Brainsway Ltd.
First quarter revenues of $3.6 million represent a quarterly record and a 68% increase over first quarter 2017 Increased market demand and leasing model continue to generate sales growth ...
Achieve TMS Announces Grand Opening of New Location in Newton, Massachusetts
23 mai 2018 09h54 HE
|
Brainsway Ltd.
NEWTON, Mass., May 23, 2018 (GLOBE NEWSWIRE) -- Achieve TMS, the largest U.S. provider of BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS), announced the opening of a new facility in...
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
07 mai 2018 08h00 HE
|
Brainsway Ltd.
The company will now have the most advanced stimulator on the market, with enhanced features that increase the ease of use for physicians and integrate a patient management system ...
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
06 mai 2018 13h25 HE
|
Brainsway Ltd.
The company will now have the most advanced stimulator on the market, with enhancedfeatures that increase the ease of use for physicians and integrate a patient management system BrainsWay will be...
Trinitas-St. Joseph’s Behavioral Health Network Offers Innovative Alternative Treatment for Depression
04 avr. 2018 08h00 HE
|
Brainsway Ltd.
PATERSON, N.J., April 04, 2018 (GLOBE NEWSWIRE) -- The Trinitas-St. Joseph’s Behavioral Health Network is now offering Transcranial Magnetic Stimulation (TMS) as a treatment option for individuals...
Brainsway Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
19 mars 2018 16h30 HE
|
Brainsway Ltd.
Increased market demand and new leasing model continue to generate significant sales growth Total minimum committed revenue projection is record $27 million for year-end 2017, up 142% versus...